Intracerebral Hemorrhage Clinical Trial
Official title:
Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral Bleedings
Background:
One third of all ICH patients require intubation and mechanical ventilation and 1/3 of all
ventilated patients require tracheostomy (i.e.≈10% of all ICH patients require
tracheostomy). As shown previously, predisposing factors for tracheostomy are hematoma
volume, hemorrhage location, presence of intraventricular hemorrhage (IVH), and occlusive
hydrocephalus as well as presence of COPD (Huttner HB et al 2006 CVD).
Sustained restricted vigilance and impaired consciousness after ICH is likely to result in
failure of extubation, raise in incidence of ventilator-associated pneumonia, increased
amount of sedative drugs and prolonged duration of neurocritical care.
Hence an early tracheostomy may be beneficial in terms of reduced duration of mechanical
ventilation.
Basic hypothesis:
Compared to patients with conventional ("late") tracheostomy between day 12 - 14, patients
with "early" tracheostomy within 72h after admission will have:
- shorter cumulative time of mechanical ventilation
- less incidence of ventilator-associated pneumonia
- less consumption of sedative drugs
- shorter duration of stay in neurocritical care unit
Randomization:
Consecutive eligible patients are randomly assigned to Either "early" tracheostomy within
72h after hospital admission Or "late" tracheostomy (= control group; undergoing
conventional tracheostomy between day 12 - 14 if extubation fails) Both groups receive
plastic tracheostomy
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05089331 -
ROSE-Longitudinal Assessment With Neuroimaging
|
||
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Active, not recruiting |
NCT04522102 -
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral haemorrhaGe (ASPIRING)-Pilot Phase
|
Phase 3 | |
Terminated |
NCT04178746 -
PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
|
||
Not yet recruiting |
NCT03956485 -
Multicentre Registry of Patients With Spontaneous Acute Intracerebral Hemorrhage in Catalonia (HIC-CAT).
|
||
Enrolling by invitation |
NCT02920645 -
Multicenter Validation of the AVICH Score
|
N/A | |
Recruiting |
NCT02625948 -
Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
|
Phase 2 | |
Completed |
NCT02478177 -
Addressing Real-world Anticoagulant Management Issues in Stroke
|
||
Completed |
NCT01971359 -
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
|
N/A | |
Completed |
NCT01261091 -
Early Tracheostomy in Ventilated Stroke Patients
|
N/A | |
Terminated |
NCT00990509 -
Albumin for Intracerebral Hemorrhage Intervention
|
Phase 2 | |
Completed |
NCT00716079 -
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial
|
N/A | |
Recruiting |
NCT00222625 -
rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
|
Phase 2 | |
Recruiting |
NCT05095857 -
The Anesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
|
Phase 4 | |
Recruiting |
NCT04548596 -
NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
|
||
Not yet recruiting |
NCT06429332 -
International Care Bundle Evaluation in Cerebral Hemorrhage Research
|
Phase 4 | |
Recruiting |
NCT05492474 -
Cranial Ultrasound for Prehospital ICH Diagnosis
|
N/A | |
Not yet recruiting |
NCT05502874 -
Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
|
||
Recruiting |
NCT04604587 -
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
|
Phase 3 | |
Recruiting |
NCT05504941 -
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
|
N/A |